🇺🇸 FDA
Pipeline program

LP-10 (Liposomal Tacrolimus)

310-001

Phase 2 small_molecule active

Quick answer

LP-10 (Liposomal Tacrolimus) for Oral Lichen Planus is a Phase 2 program (small_molecule) at LIPELLA PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
LIPELLA PHARMACEUTICALS INC.
Indication
Oral Lichen Planus
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials